---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-078865"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2026-06-29T20:32:03+00:00"
generated_at: "2026-06-29T20:33:12.587695+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics shareholders approve 2026 Stock Incentive Plan with 1.5M new shares

## Summary
- Plan adds 1,500,000 new shares; total reserve includes 2,413,730 carryover from prior plan plus returning shares.
- Shareholders approved plan with 25,872,075 for, 10,070,290 against (72% support); advisory say-on-pay also passed.
- All 12 director nominees elected; highest vote total was Kevin Tracey with 36,187,554 for, lowest was Christopher Causey with 32,342,983.
- Plan allows options, SARs, restricted stock, RSUs, stock awards, and incentive bonuses; administered by Compensation Committee.
- Effective June 26, 2026; no further grants under the 2015 plan; prior awards unaffected.

## SEC filing metadata
- accession: 0001104659-26-078865
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2026-06-29T20:32:03+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/0001104659-26-078865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465926078865/tm2619258d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-078865
- JSON: https://secwatch.observer/filing/0001104659-26-078865.json
- Plain text: https://secwatch.observer/filing/0001104659-26-078865.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.